« Previous
Next »
Journal of Evidence-Based Dental Practice
Volume 7, Issue 2
, Pages 77-78
, June 2007
Osteonecrosis of the Jaw May Not Be a Common Acute Side-Effect of Oral Bisphosphonates
References
- . Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol. 2003;21(22):4253–4254
- . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61(9):1115–1117
- . Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?. J Oral Maxillofac Surg. 2005;63(5):682–689
- . In: Phosphorus poisoning in the match industry in the United States. 1910;p. 31–47BLS
- . Matchmakers’ “phossy jaw” eradicated. Am Ind Hyg Assoc J. 1996;57(4):330–332
- . Phosphorus necrosis of the maxilla. J Oral Med. 1983;38(4):174–176
- Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. J Am Dent Assoc. 2006;137(8):1144–1150
- . Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc. 2005;136(12):1658–1668
- . Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol. 2006;35(4):236–243
- . Oral & Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaws History, Etiology, Prevention, and Treatment. Quintessence Pub Co; 2006;
PII: S1532-3382(07)00044-9
doi: 10.1016/j.jebdp.2007.03.015
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Evidence-Based Dental Practice
Volume 7, Issue 2
, Pages 77-78
, June 2007
